Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyBCTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyBCTeam Member asked a question 💭
Wake Forest, NC
December 26, 2025
 · 
Reactions
MyBCTeam

What's the difference between anastrozole and tamoxifen for breast cancer treatment?

Both anastrozole and tamoxifen are hormonal therapies used to treat hormone receptor-positive breast cancer, but they work in different ways and are used at different stages of life.

How They Work:

Anastrozole is an aromatase inhibitor Show Full Answer

What's the difference between anastrozole and tamoxifen for breast cancer treatment?

Both anastrozole and tamoxifen are hormonal therapies used to treat hormone receptor-positive breast cancer, but they work in different ways and are used at different stages of life.

How They Work:

Anastrozole is an aromatase inhibitor that blocks the production of estrogen in your body. It interferes with proteins called estrogen receptors to prevent breast cancer from returning.

Tamoxifen is a selective estrogen receptor modulator (SERM) that blocks the effect of estrogen on breast cancer cells. It stops estrogen from encouraging cancer cells to grow and divide.

When They're Used:

Anastrozole is typically prescribed for people who have gone through menopause or are under treatment to suppress their ovaries. It's most useful after menopause when the ovaries stop making estrogen.

Tamoxifen can be taken whether or not you've gone through menopause, making it an option for premenopausal women.

Effectiveness:

Clinical trials show that aromatase inhibitors like anastrozole prevent breast cancer recurrence about 30 percent more effectively than tamoxifen. This makes aromatase inhibitors the preferred first-line hormone therapy for postmenopausal people with estrogen receptor-positive breast cancer.

Both medications are usually taken long term, most commonly for five to 10 years.

December 26, 2025

Related Questions

View All
A MyBCTeam Member asked a question 💭
Whittier, CA

A MyBCTeam Member asked a question 💭
Ernul, NC

A MyBCTeam Member asked a question 💭
Mesa, AZ

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In